A- A A+

USA. Judge Rules in Favor of New York Prisoner Suing for Methadone Access

A District Court judge has issued a preliminary injunction to ensure that a 35-year-old Watertown, New York, resident can continue accessing his medication for opioid use disorder (MOUD) while detained in Jefferson County Jail. It’s the first such ruling in the Second Circuit, the Court of Appeals that includes New York state. (Filter, USA, 13.09.2021)


Strategies to maximise study retention and limit attrition bias in a prospective cohort study of men reporting a history of injecting drug use released from prison: the prison and transition health study. 

Stewart, A.C., Cossar, R., Walker, S. et al.

BMC Med Res Methodol 21, 185 (2021). doi.org/10.1186/s12874-021-01380-0


Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail. 

Lee JD, Malone M, McDonald R, et al. 

JAMA Netw Open. 2021;4(9):e2123032. doi:10.1001/jamanetworkopen.2021.23032


National Snapshot: Access to Medications for Opioid Use Disorder in U.S. Jails and Prisons

Shelly Weizman Taleed El-Sabawi Joanna Perez Melissa Baney Isaac Manoff 

O'Neill Institute, USA, July 28, 2021

THIS 50 STATE SNAPSHOT presents current laws, policies, and court actions related to access to medications for opioid use disorder (MOUD) in correctional facilities in the U.S as of April 2021. Where available, this survey also includes examples of programs that are county- or facility-specific.


The impact of the opioid crisis on U.S. state prison systems. 

Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J. 

Health Justice. 2021 Jul 24;9(1):17. doi: 10.1186/s40352-021-00143-9. PMID: 34304335; PMCID: PMC8310396.


Coronavirus (COVID-19) opioid substitution treatment in prisons - evaluation: patient experience follow-up report

Follow up report on opiate substitution therapy (OST) in Scotland’s prison during COVID-19. This report explores the experiences of patients living in prisons changing their OST prescription to Buvidal.

Scottish Government, Population Health Directorate. 07.07.2021, ISBN:



Factors Associated with Incarceration in Older Adults Experiencing Homelessness: Results from the HOPE HOME Study. 

Garcia-Grossman I, Kaplan L, Valle K, Guzman D, Williams B, Kushel M. 

J Gen Intern Med. 2021 Jun 9:1–9. doi: 10.1007/s11606-021-06897-0. Epub ahead of print. PMID: 34109543; PMCID: PMC8189551.


What are the greatest health challenges facing people who are incarcerated? We need to ask them 

Published online: June 8, 2021 

Justin Berk, Josiah D Rich, Lauren Brinkley-Rubinstein 

The Lancet Public Health 


The Harms of Incarceration: The evidence base and human rights framework for decarceration and harm reduction in prisons

This briefing provides advocates with the evidence base and human rights framework for decarceration and the provision of harm reduction services in prisons. (hri – Harm Reduction International, UK, 2021)


Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings, 

Dunlop, A. J., White, B., Roberts, J., Cretikos, M., Attalla, D., Ling, R., Searles, A., Mackson, J., Doyle, M. F., McEntyre, E., Attia, J., Oldmeadow, C., Howard, M. V., Murrell, T., Haber, P. S., and Lintzeris, N. (2021) 

Addiction. doi.org/10.1111/add.15627.


Baden-Württemberg. Ministerium der Justiz und für Europa: Medizinische Versorgung im baden-württembergischen Justizvollzug: Abschlussbericht der Expertenkommission (PDF)



Baden-Württemberg. Expertenkommission übergibt Medizinkonzept für Justizvollzug

Die Expertenkommission zur medizinischen Versorgung im baden-württembergischen Justizvollzug hat Justizminister Guido Wolf ihren Abschlussbericht übergeben. Im Bericht sind 30 konkrete Empfehlungen zur Weiterentwicklung der medizinischen Versorgung der Gefangenen angeführt. (Staatsministerium Baden-Württemberg, 19.03.2021)


Assessing factors associated with discharge from opioid agonist therapy due to incarceration in the United States. 

Marotta PL, Stringer KL, Mandavia AD, Davis A, Beletsky L, Hunt T, Goddard-Eckrich D, Wu E, Gilbert L, El-Bassel N. 

J Addict Dis. 2020 Jan-Mar;38(1):1-18. doi: 10.1080/10550887.2019.1690365. Epub 2019 Dec 10. PMID: 31821129; PMCID: PMC7224404.


Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder. 

Chappuy M, Meroueh F, Trojak B, Bachellier J, Bendimerad P, Kosim M, Hjelmström P, Nubukpo P, Brousse G, Rolland B. 

Patient Prefer Adherence. 2021 Jun 14;15:1259-1267. doi: 10.2147/PPA.S311674. PMID: 34163143; PMCID: PMC8214559.


The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases. 

Stöver, H., Tarján, A., Horváth, G. et al.

Harm Reduct J 18, 67 (2021). doi.org/10.1186/s12954-021-00506-3


EMCDDA. Prison and drugs in Europe: current and future challenges


This publication provides an overview of current knowledge and the latest developments in the field of drug use and prison in Europe. The report explores in depth the epidemiology of drug use and drug-related problems among the prison population, the available social and health service responses to drug-related problems in prison, including the most recent evidence of effectiveness, and the drug supply and markets inside prison. It also discusses recent and future challenges in this area. The report will be of interest to policymakers and their advisors, specialists and practitioners, researchers and scientists and all those concerned with the issue of prison and drugs. (EMCDDA, Lissabon, Juni 2021)


New EMCDDA report underlines need to scale up drug services in prisons

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)(1). Released on the eve of International day against drug abuse and illicit trafficking, the report, Prison and drugs in Europe: current and future challenges, takes an in-depth look at a wide range of issues in the prison setting, including drug use and harms, health and social responses and drug supply. It notes that, while, in several European countries, services in prison for people with drug problems have increased, treatment and care options available to this group remain limited and need to be scaled up. (EMCDDA, Lissabon, 25.06.2021, News release No 8/2021)


Bayern. Interview: „Letztlich empfahl der Anstaltsarzt meinem Bruder, sich im Hof Drogen zu besorgen“

Claudia Jaworski hat ihrem heroinabhängigen Bruder Substitutionsmittel ins Gefängnis gebracht, weil ihm in Haft die Behandlung verweigert wurde – und steht nun selbst vor Gericht. Aus einer besorgten Schwester wurde eine Aktivistin. (Deutsche AIDS-Hilfe, hiv-magazin, 14.06.2021)


Substitution in Haft: Für eine wissenschaftlich-basierte Substitutionspraxis in bayerischen Haftanstalten

Positionspapier von: AG Aids&Haft in Bayern, AIDS-HilfeNürnberg-Erlangen-Fürth, Akzepte.V.–Bundesverband für akzeptierende Drogenarbeit und humane Drogenpolitik, Augsburger Aids-Hilfe, Caritasverband für die Diözese Augsburg e.V., Condrobs e.V. Deutsche Aidshilfe, Bayerische AIDS Stiftung, Verein zur Gesundheitsförderung e.V., Dick und Dünn Nürnberg e.V.-Fachberatung bei Essstörungen –Jugendberatung bei Essstörungen, Drogenhilfe Schwaben gGmbH, Dr. Thomas Galli für die Deutsche Gesellschaft zur humanen Fortentwicklung des Strafrechts, Extra e.V.-Suchthilfe für Frauen und Angehörige, MünchnerAIDS-Hilfe, Prope.V.–Drogennotdienst München L43, Strafvollzugsarchiv e.V.–Strafvollzugsarchiv an der Fachhochschule Dortmund, Therapieverbund Sucht-Caritasverband der Erzdiözese München und Freising e.V.

München im Juni 2021



Below you will find information and resources to help you advocate for policies to improve addiction prevention, treatment, and recovery and remission in correctional settings. (ASAM – American Society of Addiction Medicine, 2021)


USA. ‘We were blown away to see the success’: Kane County Jail drug treatment program slashes post-incarceration overdoses

(…) The jail has a voluntary in-house drug treatment program that includes a still-rare feature: Inmates who are addicted to heroin, OxyContin and other opioids can receive buprenorphine, a medication that is itself an opioid and can stave off withdrawal, lessen drug cravings and protect against overdose. (Chicago Tribune, USA, 23.04.2021)


Behandlung opioidabhängiger Inhaftierter - Einstellungen und Behandlungspraxis des medizinischen Personals in bayerischen Justizvollzugsanstalten

Maren Weiss, Kerstin Geißelsöder, Maike Breuer, Norbert Wodarz

Das Gesundheitswesen, March 2021, DOI: 10.1055/a-1399-9286



USA. Exclusive: ACLU Sues NY County Over Methadone Access in Prison

The New York Civil Liberties Union (NYCLU) and American Civil Liberties Union (ACLU) filed a lawsuit against Jefferson County in Upstate New York on April 5. It seeks to compel the Jefferson County Correctional Facility to provide access to methadone treatment for opioid use disorder (OUD). (Filter, USA, 05.04.2021)


USA. Initiating methadone in jail: Is it cost effective?

Medications for opioid use disorder (e.g., methadone, Suboxone) may be particularly useful in jails and prisons because of their ability to reduce overdose risk after release. However, few studies have looked at the cost-effectiveness of such services, meaning that the benefits and use of services are worth the financial resources needed to provide them. Cost-effectiveness studies help to inform the utility and feasibility of expanding services nationally. In this study, the researchers evaluated the cost and cost-effectiveness of two methadone treatment interventions to produce negative drug tests one year after release. Results showed that methadone treatment provided along with services that facilitate community-based treatment navigation, akin to “recovery coaching”, appear to be the most cost-effective option. (Recovery Research Institute, USA, 22.03.2021)


"My first 48 hours out": drug users' perspectives on challenges and strategies upon release from prison. 

Jamin D, Vanderplasschen W, Sys O, Jauffret-Roustide M, Michel L, Trouiller P, Neisa A, Homen M, Mendes V, Stöver H. 

Harm Reduct J. 2021 Mar 12;18(1):32. doi: 10.1186/s12954-021-00480-w. PMID: 33712032; PMCID: PMC7953692.


USA. Woman who sued DuPage County to receive methadone in jail as treatment for opioid addiction will get her meds

DuPage County officials agreed to provide methadone to a recovering opioid user who is serving a month in jail, federal court records indicate.

Christine Finnigan, 53, sued the county last month for an assurance she could receive her medication once she entered jail to serve a 30-day sentence for drunken driving. She has been on methadone since 2019 to help her combat a long-standing opioid addiction. (Chicago Tribune, USA, 26.02.2021)


Integrating episodes of imprisonment and the cascade of care for opioid use disorder. 

Cossar, R. D., Stewart, A. C., Winter, R., Curtis, M., Dietze, P. M., Ogloff, J. R. P., and Stoove, M. (2021)

Addiction, 116: 427– 428. doi.org/10.1111/add.15245.


USA. Judge Grants Class Action Status to Methadone-Taper Jail Lawsuit

A federal judge has paved the way for a case against a methadone-taper policy at Cook County Jail, Illinois to proceed as a class action lawsuit. (Filter, USA, 07.12.2020)


Fifteen years of heroin-assisted treatment in a Swiss prison—a retrospective cohort study. 

Liebrenz, M., Gamma, A., Buadze, A. et al.

Harm Reduct J 17, 67 (2020). doi.org/10.1186/s12954-020-00412-0


Bayern. Auf Entzug: Fehlende Behandlung für Heroinabhängige in Haft?

Heroinsucht gilt als schwere chronische Krankheit. Doch in bayerischen Gefängnissen werden Heroinersatzbehandlungen immer wieder abgebrochen. Experten kritisieren das scharf. (BR24, 28.10.2020)